The procedure to induce hyperalgesic priming was based on a previously described protocol12 (link)20 (link). The inducer of priming (ryanodine or PPT, in this study) was injected intradermally on the dorsum of the hind paw, at the site of nociceptive testing. The presence of priming was confirmed, 3–5 days later, depending on the experiment, by the injection of PGE2 (100 ng), at the same site. The mechanical hyperalgesia induced by injection of PGE2 in the previously untreated naïve control paw lasts no more than 2 h57 (link), and in this study is represented by the reduction in the mechanical threshold evaluated 30 min after PGE2 injection, which expresses its acute hyperalgesic effect, even in the previously primed paw11 (link)12 (link); The prolongation of PGE2 hyperalgesia to greater than 4 h is used as a marker for the presence of priming7 (link)10 (link)12 (link)58 (link), produced by activation of an additional signaling pathway9 (link)11 (link)12 (link), and represented as the reduced mechanical threshold at the 4th h time point12 (link). Importantly, immediately before the tests for priming with PGE2, the mechanical nociceptive threshold is not significantly different from the mechanical baseline threshold evaluated before the injection of the priming inducer (3–5 days previously, see Supplementary Table S1 ).
Full text: Click here